화일약품

061250KOSDAQ

60.5 / 100

Reference Date: 2026-09-08

Financial Score20.0 / 40

News Sentiment12.5 / 25

Momentum18.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 3.4% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Hwa-il Pharm Co., Ltd. is a company engaged in the production and sale of pharmaceutical raw materials, finished pharmaceuticals, and functional health food ingredients, with three domestic production facilities and an expansion plan for the Pyeongtaek plant. The business is accelerating growth due to the expansion of the generic drug market and increased demand for antibiotics, with sales reaching 100.8 billion KRW in 2025.

Number of Employees

145people

Average Salary

61.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.37Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-0.11Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

0.13Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼9.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼232.5% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 1.8% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position8.0Point

Near 52w high (94%, uptrend)

Current 9,020Won52-week high 9,53052-week low 918

1-month return4.0Point

1m +3.44% (slight rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-13